CHR Velocity as a predictor of early molecular response in patients with chronic myeloid leukemia.

被引：1
|
作者：
Malhotra, Pankaj
Chikkodi, Santosh V.
Naseem, Shano
Khadwal, Alka
Prakash, Gaurav
Kumari, Savita
Suri, Vikas
Varma, Neelam
Varma, Subhash
机构：
[1] PGIMER, Chandigarh, India
[2] Nehru Hosp, Chandigarh, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e18038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18038
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MEAN CORPUSCULAR VOLUME CAN BE AN EARLY PREDICTOR FOR MOLECULAR RESPONSE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS
    Ozkan, M. Comert
    Kaya, E.
    Cirik, S.
    Kuku, I.
    Erkurt, M.
    LEUKEMIA RESEARCH, 2017, 61 : S28 - S28
  • [2] Molecular diagnosis of chronic myeloid leukemia.
    Misyurin, A. V.
    Aksyonova, E. V.
    Krutov, A. A.
    Lukyanenko, A. V.
    Finashutina, Yu. P.
    Suchkova, M. V.
    Tikhonova, V. V.
    Chelysheva, E. Yu.
    Soldatova, I. N.
    Turkina, A. G.
    Khoroshko, N. D.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (02): : 35 - 40
  • [3] Velocity of Early BCR-ABL Transcript Elimination As an Optimized Predictor of Deep Molecular Response in Chronic Myeloid Leukemia Patients in Chronic Phase on Treatment with Dasatinib
    Murai, Kazunori
    Yamaguchi, Kohei
    Ito, Shigeki
    Akagi, Tomoaki
    Ogawa, Kazuei
    Mitsue, Inomata
    Meguro, Kuniaki
    Watanabe, Reiko
    Miyagishima, Takuto
    Wakasa, Kentaro
    Shindo, Motohiro
    Tsukushi, Yasuhiko
    Kubo, Kohmei
    Oba, Koji
    Sakamoto, Junichi
    Ishida, Yoji
    BLOOD, 2015, 126 (23)
  • [4] Molecular resistance to imatinib in chronic myeloid leukemia. From the Italian Cooperative Study Group on chronic myeloid leukemia.
    Martinelli, G
    Soverini, S
    Rosti, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    de Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2003, 102 (11) : 312B - 312B
  • [5] Early Molecular Response in Chronic Myeloid Leukemia Patients Predicts Future Response Status
    Martynkevich, Irina
    Shuvaev, Vasily
    Petrova, Ekaterina
    Polushkina, Lyubov
    Martynenko, Lyudmila
    Ivanova, Marina
    Cybakova, Natalya
    Kleina, Elizaveta
    Shabanova, Elena
    Fominykh, Mikhail
    Abdulkadyrov, Kudrat
    BLOOD, 2014, 124 (21)
  • [6] Early molecular response in chronic myeloid leukemia patients predicts future response status
    Kagita, Sailaja
    Jiwtani, Sangeeta
    Uppalapati, Srihari
    Linga, Vijay Gandhi
    Gundeti, Sadasivudu
    Digumarti, Raghunadharao
    TUMOR BIOLOGY, 2014, 35 (05) : 4443 - 4446
  • [7] Cytogenetics and molecular characterization of the apheresis products in patients with chronic myeloid leukemia.
    Carrasco, M
    Sureda, A
    Martínez, C
    Limón, A
    Martino, R
    Altés, A
    Brunet, S
    Martín-Henao, GA
    Aventín, A
    Sierra, J
    BLOOD, 2000, 96 (11) : 253B - 253B
  • [8] Russian register of patients with chronic myeloid leukemia.
    Turkina, A. G.
    Vinogradova, O. Yu.
    Khoroshko, N. D.
    Vorobyov, A. I.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2007, 52 (02): : 7 - 11
  • [9] Molecular relapse in PBSCT and BMT for chronic myeloid leukemia.
    Oehler, VG
    Guthrie, KA
    Gooley, T
    Beppu, LW
    Radich, JP
    BLOOD, 2002, 100 (11) : 548A - 549A
  • [10] Assessment of Early Molecular Response in Tunisian Chronic Myeloid Leukemia
    Frikha, Rim
    Elloumi, Moez
    Kamoun, Hassen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S230 - S230
12345